Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
This locus encodes the transforming growth factor (TGF)-beta type III receptor. Additionally we are shipping TGFBR3 Antibodies (141) and TGFBR3 Proteins (10) and many more products for this protein.
Showing 5 out of 21 products:
Inhibition of genes for betaglycan and FIBP (show FIBP ELISA Kits) in granulosa cells in vitro suggests that they inhibit estradiol production in regressing subordinate follicles.
We suggest that TGFBR3 protein expression is involved in up-regulated TGF-beta (show TGFB1 ELISA Kits) signaling in Marfan syndrome patients with a dominant negative FBN1 (show FBN1 ELISA Kits) gene mutation.
describe a detailed characterization of TbetaRIII expression in lymphocyte subpopulations demonstrating that this co-receptor is significantly expressed in T but not B lymphocytes and among them, preferentially expressed on naive and central memory T cells
TGF-beta (show TGFB1 ELISA Kits) type I, II, and III receptors were all identified in pregnant serum; all were substantially elevated in early-onset but not late-onset PE. Endoglin (show ENG ELISA Kits) was increased in both subtypes.
TGFBR3 and/or MGEA5 rearrangements are much more common in hybrid hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas.
opposing functions for the different GAG modifications on TbetaRIII suggesting that Wnt (show WNT2 ELISA Kits) interactions with the TbetaRIII heparan sulfate chains result in inhibition of Wnt (show WNT2 ELISA Kits) signaling, likely via Wnt (show WNT2 ELISA Kits) sequestration, whereas the chondroitin sulfate GAG chains on TbetaRIII promote Wnt3a (show WNT3A ELISA Kits) signaling.
Results suggest that high expression levels of alpha-inhibin and beta-glycan transcripts in secretory phase endometrium are associated with a lower chance of achieving pregnancy with in vitro fertilization.
Results show decreased TbetaRIII expression with hepatocellullar carcinoma (HCC) progression leading to the activation of Smad2 (show SMAD2 ELISA Kits) and suggest that TbetaRIII acts as a suppressive factor in regulating the migration and invasion of HCC, by inhibiting Smad2 (show SMAD2 ELISA Kits) and Akt (show AKT1 ELISA Kits) pathways.
Study shows that TbetaRIII expression is significantly decreased in salivary glands adenoid cystic carcinoma (ACC) patients and defines TbetaRIII as a biomarker exerting antitumor action on ACC progression.
No correlation of loss of heterozygosity at the TGFBR3 locus with clinicopathological parameters suggests that allelic imbalance may be an early genetic event during neoplastic transformation of human endometrium.
Study shows that GDF10 (show GDF10 ELISA Kits) is down-regulated in patients with oral squamous cell carcinoma, and is an independent risk factor for overall survival. Its expression is regulated by TGFBR3 which shares the signaling inhibiting epithelial-mesenchymal transition.
TGFbetaR3 promotes apoptosis of cardiomyocytes via a p38 (show CRK ELISA Kits) pathway-associated mechanism, and loss of TGFbetaR3 reduces myocardial infarction injury.
BMP2 (show BMP2 ELISA Kits) also requires Src (show SRC ELISA Kits) for filamentous actin polymerization in Tgfbr3(-/-) epicardial cells.
Study identified a novel major binding site for TGF-beta (show TGFB1 ELISA Kits)-like growth factors in TGFR-3. Findings potentially provide novel experimental insight into the general function of zona pellucida domain-containing proteins.
Retinoic acid enhanced TbetaRIII expression and that this increase contributed to LF-stimulated IgA (show IgA ELISA Kits) production.
Pro-fibrotic cardiac effect of miR (show MLXIP ELISA Kits)-328 was mediated by down-regulating TGFbR3 and up-regulating TGFb1 (show TGFB1 ELISA Kits).
These data demonstrate that TbetaRIII regulates BMP-mediated signaling and biological effects, primarily through the ligand sequestration effects of sTbetaRIII in normal and cancerous mammary epithelial cells.
Glucocorticoids recruit Tgfbr3 and Smad1 (show SMAD1 ELISA Kits) to shift transforming growth factor-beta signaling from the Tgfbr1 (show TGFBR1 ELISA Kits)/Smad2 (show SMAD2 ELISA Kits)/3 axis to the Acvrl1 (show ACVRL1 ELISA Kits)/Smad1 (show SMAD1 ELISA Kits) axis in lung fibroblasts.
work reveals a 'seed and soil' mechanism where TGF-beta2 (show TGFB2 ELISA Kits) and TGF-beta (show TGFB1 ELISA Kits)-RIII signalling through p38alpha (show MAPK14 ELISA Kits)/beta regulates DTC dormancy and defines restrictive (BM) and permissive (lung) microenvironments for HNSCC metastasis
TGFBR3 mediated suppression of cancer progression includes effects on the tumor immune microenvironment.
This study provides evidence that the expressions of inhibin alpha subunit (show INHA ELISA Kits) and betaglycan are inferior in cystic follicles, and this may be caused by the decrease in FSH (show BRD2 ELISA Kits) in the presence of a cystic follicle.
This locus encodes the transforming growth factor (TGF)-beta type III receptor. The encoded receptor is a membrane proteoglycan that often functions as a co-receptor with other TGF-beta receptor superfamily members. Ectodomain shedding produces soluble TGFBR3, which may inhibit TGFB signaling. Decreased expression of this receptor has been observed in various cancers. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene.
transforming growth factor, beta receptor III
, transforming growth factor, beta receptor III (betaglycan, 300kDa)
, transforming growth factor beta receptor type 3-like
, TGF-beta receptor type 3
, TGF-beta receptor type III
, betaglycan proteoglycan
, transforming growth factor beta receptor type 3
, transforming growth factor, beta receptor 3
, TGF-beta type III receptor
, transforming growth factor beta receptor III
, transforming growth factor-beta type III receptor